Stock NRBO NEUROBO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart NeuroBo Pharmaceuticals, Inc.

Equities

NRBO

US64132R4048

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
4.54 USD +0.22% Intraday chart for NeuroBo Pharmaceuticals, Inc. +1.56% +22.82%
Jun. 26 NeuroBo Pharmaceuticals, Inc. Doses First Patient in the MAD Part 2 of its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity CI
Jun. 26 NeuroBo Pharmaceuticals Raises $20 Million from Share Placement MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NEUROBO PHARMACEUTICALS, INC.
Bio Therapeutic Drugs
+0.22%+1.56%+22.82%+30.43% - 37.21M
Bullish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. NRBO Stock
  4. Charts NeuroBo Pharmaceuticals, Inc.
  5. Comparison Chart